Jiangsu Nhwa Pharmaceutical Hits Day Low Amid Price Pressure at CNY 21.87

Jiangsu Nhwa Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.69% as it reached an intraday low of CNY 21.87. This performance stands in contrast to the China Shanghai Composite, which saw a slight increase of 0.04% on the same day. Over the past week, Jiangsu Nhwa's stock has shown minimal movement, with a decrease of just 0.05%. However, its performance over the last month has been more positive, reflecting a gain of 4.28%. In the longer term, the stock has faced challenges, with a year-to-date decline of 9.03% and a significant drop of 11.85% over the past year. Financial metrics indicate that the company has a market capitalization of CNY 22,307 million and a price-to-earnings ratio of 17.00. Despite a high dividend yield of 1.57%, the company has reported a decrease in net profit and has consistently underperformed against the benchmark over the last three years. The return on equity stands at 12.80%, while the debt-equity ratio is noted at -0.45, reflecting the company's financial structure.